| Literature DB >> 35005548 |
Shuhei Koide1,2, Valgardur Sigurdsson1, Visnja Radulovic1, Kiyoka Saito1,3, Zhiqian Zheng2, Stefan Lang4, Shamit Soneji4, Atsushi Iwama2, Kenichi Miharada1,3.
Abstract
Isolation of long-term hematopoietic stem cell (HSC) is possible by utilizing flow cytometry with multiple cell surface markers. However, those cell surface phenotypes do not represent functional HSCs after in vitro culture. Here we show that cultured HSCs express mast cell-related genes including Cd244. After in vitro culture, phenotypic HSCs were divided into CD244- and CD244+ subpopulations, and only CD244- cells that have low mast cell gene expression and maintain HSC-related genes sustain reconstitution potential. The result was same when HSCs were cultured in an efficient expansion medium containing polyvinyl alcohol. Chemically induced endoplasmic reticulum (ER) stress signal increased the CD244+ subpopulation, whereas ER stress suppression using a molecular chaperone, TUDCA, decreased CD244+ population, which was correlated to improved reconstitution output. These data suggest CD244 is a potent marker to exclude non-functional HSCs after in vitro culture thereby useful to elucidate mechanism of functional decline of HSCs during ex vivo treatment.Entities:
Keywords: Biological sciences; Cell biology; Immunology; Stem cells research
Year: 2021 PMID: 35005548 PMCID: PMC8718822 DOI: 10.1016/j.isci.2021.103603
Source DB: PubMed Journal: iScience ISSN: 2589-0042
Figure 1Transplantation of HSCs cultured with various bile acids
(A) The gating strategy for isolating CD150+CD48−KSL cells from murine bone marrow.
(B) Experimental design of the competitive reconstitution assay. Fifty (50) CD150+CD48−KSL cells were isolated from BM of Ly5.1 mice (donor, two mice per experiment were used) and cultured in Stemspan SFEM medium supplemented with 100 ng/mL mSCF and 100 ng/mL hTPO with or without 100 μM of different types of bile acids (BA) for 7 or 14 days. Cells were then transplanted into lethally irradiated Ly5.2 mice (recipient, 5–18 mice) along with 2 × 105 total BM cells derived from Ly5.1/5.2 (F1) mice (competitor). Donor contribution (chimerism) was monitored by analyzing peripheral blood (PB) every month.
(C) Peripheral blood analysis of the transplanted mice. Chimerism in PB at 16 weeks of transplanted mice are shown. Mean ± SD from three independent experiments (n = 5–18) are displayed. Significance was calculated using one-way ANOVA within the same culture days. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
(D–F) Cell surface expression of CD48 on KSL fraction of HSCs cultured with or without BA. Representative FACS plots (C) and summary of the flow cytometry analyses (D and E) are shown. Mean ± SD (n = 3) are displayed.
Figure 2Gene expression changes in CD48−KSL cells upon in vitro culture and aging
(A) Experimental design of the gene expression analysis. Five hundred CD48−KSL cells were sorted from BM of young (10 weeks old, YF) mice. Cells were also cultured in Stemspan SFEM medium supplemented with 100 ng/mL mSCF and 100 ng/mL hTPO for 14 days, and CD48−KSL cells were re-sorted.
(B) Volcano plot showing differentially expressed genes between YF and YC. Significant difference was defined as p < 0.001 and log2 fold change < −2 (blue) or >2 (red).
(C) Heatmaps showing a list of differentially expressed genes. Significant difference was defined as p < 0.0001 and log2 fold change < −3 or >3. Blue arrowheads indicate CD markers.
(D) Gene set enrichment analysis (GSEA) of the microarray data comparing YF and YC. NES, normalized enrichment score; NOM p-val, nominal p value; FDR q-val, false discovery rate q-value. See also Table S1.
Figure 3CD244 expression divides CD48−KSL cells into functionally distinct subpopulations after in vitro culture
(A) Experimental design of the in vitro culture experiment. One hundred CD48−KSL cells were sorted from BM of young mice and cultured in Stemspan SFEM medium supplemented with 100 ng/mL mSCF and 100 ng/mL hTPO for 7 days.
(B) Expression patterns of CD244 and CD48 on the cell surface of fresh and 14 days cultured KSL cells. Representative FACS plots on KSL population are shown.
(C and D) qRT-PCR analysis for HSC-related genes and mast cell-related genes in CD244+CD48−KSL cells compared with the CD244+CD48−KSL counterpart. Representative FACS plot and gating of CD244+CD48−KSL cells (green) and CD244−CD48−KSL cells (red) on 7 days cultured KSL cells are shown in (C). Relative expression levels of genes in CD244+CD48−KSL cells to CD244−CD48−KSL are shown in (D).
(E) Competitive reconstitution assay. After 7 days’ culture, two subpopulations were sorted and 1,000 of CD244- or 1,500 of CD244+CD48−KSL cells were separately transplanted into lethally irradiated recipient mice (seven mice) with 2 × 105 total BM cells (competitor). Chimerism was monitored by analyzing PB every month. Significance was calculated using Student's t test at each time point. Mean ± SD from two independent experiments (n = 7) are displayed. ∗∗∗∗p < 0.0001.
(F) Lineage balance of donor-derived cells in the PB of recipient mice. Mean ± SD from two independent experiments (n = 6) are displayed. ∗∗p < 0.01, ∗∗∗∗p < 0.0001. Each color represents different lineages.
(G) Analysis of BM from engrafted mice after 16 weeks. Chimerism in each cell fraction is shown. Significance was calculated using Student's t test. Mean ± SD from two independent experiments (n = 6) are displayed. ∗∗p < 0.01.
(H and I) Limiting dilution assay for CD244−CD48−KSL cells. CD244−CD48−KSL cells were re-sorted after 7 days’ in vitro culture and 200, 40, or 10 cells were transplanted to recipient mice in a competitive manner. Chimerism above 1% was judged as successful engraftment. The frequency of functional HSC was calculated using ELDA (http://bioinf.wehi.edu.au/software/elda/). Chimerism of individual mice is shown in (I).
Figure 4ER stress induction and cytokine signals affect CD244 expression
(A) Expression patterns of CD244 and CD48 on KSL cells after in vitro culture in Stemspan SFEM medium supplemented with 100 ng/mL mSCF and 100 ng/mL hTPO for 7 days, and with or without 0.5 μg/mL Tunicamycin or 100 μM TUDCA. Representative FACS plots are shown.
(B) Summary of the flow cytometry analyses. Frequencies of KSL cells, CD48- fraction in KSL population, and CD244−CD48- fraction in KSL population are shown. Mean ± SD from two independent experiments (n = 5–11) are displayed. Significance was calculated using one-way ANOVA within each population. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001.
(C) A heatmap showing frequencies of CD244−CD48−KSL cells after 7 days’ culture with various SCF/TPO concentrations. Mean values of Z score (n = 3) in each fraction are displayed.
Figure 5Gene expression profiling of CD244- and CD244+ KSL cells
(A) Experimental design of the gene expression analysis. Five hundred CD244-48−KSL cells were sorted from BM of 10-week-old mice (N) and were also cultured in Stemspan SFEM medium supplemented with 100 ng/mL mSCF and 100 ng/mL hTPO for 7 days, and CD244−KSL (CN) and CD244+KSL (CP) cells were re-sorted.
(B) Volcano plot showing differentially expressed genes between CP versus N (left), CN versus N (center), and CP versus CN (right). Significant difference was defined as p < 0.01 and log2 fold change < −2 (blue) or >2 (red).
(C) K-mean clustering of genes showing different expression patterns between the three cohorts and heatmaps of selected genes. Significant difference was defined as p < 0.001 and log2 fold change < −2 or >2.
(D) Overlap of hallmarks and GO terms between the three groups based on GSEA. See also Table S2.
Figure 6CD244 expression distinguishes functionally distinct subpopulations after in vitro culture in PVA medium
(A) Experimental design of the in vitro culture experiment. One hundred CD48−KSL cells were sorted from BM of young mice and cultured in PVA containing medium (Wilkinson et al., 2019) supplemented with 10 ng/mL mSCF and 100 ng/mL hTPO for 7 days.
(B) Expression patterns of CD244 and CD48 on the cell surface of KSL cells after in vitro culture in PVA medium. A representative FACS plot on KSL population is shown.
(C) Competitive reconstitution assay. After 7 days’ culture, three subpopulations were sorted and 500 of CD244−CD48−KSL cells, CD244−CD48+KSL cells, or CD244+CD48+KSL cells were separately transplanted into lethally irradiated recipient mice with 2 × 105 total BM cells. Chimerism was monitored by analyzing PB every month. Significance was calculated using one-way ANOVA at each time point. Mean ± SD from two independent experiments (n = 12) are displayed. ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001
(D) Lineage balance of donor-derived cells in the PB of recipient mice. Significance was calculated using one-way ANOVA at each time point. Mean ± SD from two independent experiments (n = 12) are displayed. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. Each color represents different lineages.
(E) Analysis of BM from engrafted mice after 16 weeks. Chimerism in each cell fraction is shown. Significance was calculated using one-way ANOVA within each population. Mean ± SD from two independent experiments (n = 5) are displayed. ∗∗∗∗p < 0.0001.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Rat anti-mouse B220 (RA3-6B2), APC | BioLegend | Cat# 103212; RRID: |
| Rat anti-mouse B220 (RA3-6B2), PE/Cy5 | BioLegend | Cat# 103210; RRID: |
| Armenian Hamster anti-mouse CD3ε (145-2C11), APC | BioLegend | Cat# 100312; RRID: AB_ 312677 |
| Armenian Hamster anti-mouse CD3ε (145-2C11), Biotin | BioLegend | Cat# 100304; RRID: AB_ 312669 |
| Armenian Hamster anti-mouse CD3ε (145-2C11), PE/Cy5 | BioLegend | Cat# 100310; RRID: |
| Rat anti-mouse CD4 (L3T4), APC/Cy7 | BioLegend | Cat# 100526; RRID: |
| Rat anti-mouse CD4 (GK1.5), Biotin | BioLegend | Cat# 100404; RRID: |
| Rat anti-mouse CD4 (H129.19), FITC | BioLegend | Cat# 130308; RRID: |
| Rat anti-mouse CD8a (53-6.7), APC/Cy7 | BioLegend | Cat# 100714; RRID: AB_ 312747 |
| Rat anti-mouse CD8a (53-6.7), PE | BioLegend | Cat# 100708; RRID: AB_ 312747 |
| Rat anti-mouse CD11b (M1/70), Biotin | BioLegend | Cat# 101204; RRID: |
| Rat anti-mouse CD11b (M1/70), PE | BioLegend | Cat# 101208; RRID: |
| Rat anti-mouse CD11b (M1/70), PE/Cy5 | BioLegend | Cat# 101210; RRID: |
| Mouse anti-mouse CD45.1 (A20), Brilliant Violet 510™ | BioLegend | Cat# 110741; RRID: |
| Rat anti-mouse CD45.1 (A20), PE/Cy7 | BioLegend | Cat# 110730; RRID: |
| Rat anti-mouse CD45.1 (A20), PerCP | BioLegend | Cat# 110726; RRID: |
| Mouse anti-mouse CD45.2 (104), APC | BioLegend | Cat# 109814; RRID: |
| Mouse anti-mouse CD45.2 (104), FITC | BioLegend | Cat# 109806; RRID: |
| Mouse anti-mouse CD45.2 (104), Brilliant Violet 421™ | BioLegend | Cat# 109832; RRID: |
| Mouse anti-mouse CD45.2 (104), Brilliant Violet 785™ | BioLegend | Cat# 109839; RRID: |
| Mouse anti-mouse CD45.2 (104), PE | BioLegend | Cat# 109808; RRID: |
| Rat anti-mouse CD48 (HM48-1), APC | BioLegend | Cat# 103412; RRID: |
| Rat anti-mouse CD48 (HM48-1), FITC | BioLegend | Cat# 103404; RRID: |
| Rat anti-mouse CD150 (TC15-12F12.2), PE/Cy7 | BioLegend | Cat# 115914; RRID: |
| Rat anti-mouse CD244.2 (m2B4), PE | BioLegend | Cat# 133508; RRID: |
| Rat anti-mouse c-kit (2B8), APC | BioLegend | Cat# 105812; RRID: |
| Rat anti-mouse c-kit (2B8), APC/Cy7 | BioLegend | Cat# 105826; RRID: |
| Armenian Hamster anti-mouse FcεRIα (MAR-1), FITC | BioLegend | Cat# 134306; RRID: |
| Rat anti-mouse Ly-6G/Ly-6C (Gr-1) (RB6-8C5), PE | BioLegend | Cat# 108408; RRID: |
| Rat anti-mouse Ly-6G/Ly-6C (Gr-1) (RB6-8C5), PE/Cy5 | BioLegend | Cat# 108410; RRID: |
| Rat anti-mouse Ly-6A/E (Sca-1) (D7), FITC | BioLegend | Cat# 108106; RRID: |
| Rat anti-mouse Ly-6A/E (Sca-1) (D7), Brilliant Violet 421™ | BioLegend | Cat# 108127; RRID: |
| Rat anti-mouse Ter119 (TER119), Biotin | BioLegend | Cat# 116204; RRID: |
| Rat anti-mouse Ter119 (TER119), PE/Cy5 | BioLegend | Cat# 116210; RRID: |
| Streptavidin-APC | BioLegend | Cat# 405207 |
| Streptavidin-Brilliant Violet 605™ | BD | Cat# 563260 |
| Rat anti-mouse CD34 (RAM34), FITC | eBioscience | Cat# 11-0341-85; RRID: |
| Rat anti-mouse CD201 (eBio1560), APC | eBioscience | Cat# 17-2012-82; RRID: |
| Rat anti-mouse c-kit (2B8), APC-eFluor 780 | Thermo Fisher Scientific | Cat# 47-1171-82; RRID: |
| Rat anti-mouse CD8a (53-6.7), Biotin | TONBO | Cat# 20-0081-U100 |
| 7-Amino-Actinomycin-D (7AAD) | Sigma-aldrich | Cat# A9400-1MG |
| CD117 MicroBeads, mouse | Miltenyi Biotec | Cat# 130-091-224 |
| Recombinant Murine stem cell factor (mSCF) | PEPROTECH | Cat# 250-03-10 μg |
| Recombinant Mouse thrombopoietin (mTPO) | PEPROTECH | Cat# AF-315-14-10 μg |
| Recombinant Human thrombopoietin (hTPO) | PEPROTECH | Cat# 300-18-10μg |
| 2-Mercaptoethanol | Sigma-aldrich | Cat# M6250-100ML |
| Ham’s F-12 Nutrient Mix | Gibco | Cat# 11765054 |
| StemSpan™ SFEM | Stem Cell Technologies | Cat# 09650 |
| HEPES | Thermo Fisher Scientific | Cat# 15630080 |
| Penicillin–Streptomycin–Glutamine | Thermo Fisher Scientific | Cat# 10378016 |
| Insulin–Transferrin–Selenium–Ethanolamine (ITS-X) | Thermo Fisher Scientific | Cat# 51500056 |
| Polyvinyl alcohol (87–90%-hydrolyzed) | Sigma-Aldrich | Cat# P8136-250G |
| Taurochenodeoxycholic acid | Sigma-Aldrich | Cat# T6260 |
| Taurocholic acid | Sigma-Aldrich | Cat# T9034 |
| Tauro-α-muricholic acid | Toronto Research Chemicals | Cat# T009130 |
| Tauro-β-muricholic acid | Santa Cruz | Cat# sc-361829 |
| Tauroursodeoxycholic acid | Sigma-Aldrich | Cat# T0266 |
| RNeasy Micro Kit | QIAGEN | Cat# 74004 |
| Ki-67 staining Kit | BD | Cat# 556026 |
| Click-IT™ L-Homopropargylglycine (HPG) | Thermo Fisher Scientific | Cat# C10186 |
| Click-iT™ Plus Alexa Fluor™ 488 Picolyl Azide Toolkit | Thermo Fisher Scientific | Cat# C10641 |
| BD Cytofix/Cytoperm™ Fixation/Permeabilization Solution Kit | Thermo Fisher Scientific | Cat# BDB554714 |
| Microarray analysis | NCBI Gene Expression Omnibus (GEO) database | Accession number: |
| Mouse: C57BL/6 (CD45.2) | Taconic | N/A |
| Mouse: B6.SJL (CD45.1) | In-house breeding | N/A |
| Quantitative real-time PCR probe for | Thermo Fisher Scientific | Mm00483940_m1 |
| Quantitative real-time PCR probe for | Thermo Fisher Scientific | Mm00438867_m1 |
| Quantitative real-time PCR probe for | Thermo Fisher Scientific | Mm01189735_g1 |
| Quantitative real-time PCR probe for | Thermo Fisher Scientific | Mm04204611_g1 |
| Quantitative real-time PCR probe for | Thermo Fisher Scientific | Mm00442834_m1 |
| Quantitative real-time PCR probe for | Thermo Fisher Scientific | Mm00723157_m1 |
| Quantitative real-time PCR probe for | Thermo Fisher Scientific | Mm03024075_m1 |
| Quantitative real-time PCR probe for | Thermo Fisher Scientific | Mm01267402_m1 |
| Quantitative real-time PCR probe for | Thermo Fisher Scientific | Mm00440310_m1 |
| Gene Expression Commons | RIKEN | |
| FlowJo | Tree Star | N/A |
| ELDA | WEHI | |
| Prism | Graphpad | N/A |